NCT04458454View on ClinicalTrials.gov

"Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles"

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

December 2, 2019

Primary Completion Date

February 20, 2020

Study Completion Date

February 20, 2020

Conditions
InfertilityReproductive Techniques, AssistedOocyte Maturation
Interventions
DIAGNOSTIC_TEST

Relaxin ELISA Kit

Ovarian stimulation was carried out from day 3 of the menstrual cycle using a fixed protocol, with recombinant (Gonal-F, Pergoveris) or human menopausal gonadotropins (Meriofert), GnRH antagonist (ganirelix 0.25 mg). A recombinant human chorionic gonadotropin Ovitrel 250 μg or a GnRH agonist, Diferelin 0.2 mg, was used as an ovulation trigger.

Trial Locations (1)

Unknown

DOOttResearch, Saint Petersburg

All Listed Sponsors
lead

D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology

OTHER

NCT04458454 - "Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles" | Biotech Hunter | Biotech Hunter